prof. Frederik Berrevoet (MD, PhD)
Head of Department of General and HPB Surgery and Liver Transplantation
Coordinating Supervisor Surgical internship University Gent
Secretary General Royal Belgian Society of Surgery
Vice-Chair Educational Committee EAHPBA
Advisory Board Member for Science European Hernia Society
Treasurer UEMS Division HPB Surgery
The objective of our research group is to advance the field of surgical oncology through the integration of computer sciences and artificial intelligence (AI) techniques. This research focuses on leveraging AI algorithms and computational modeling to analyze complex cancer data, aiming to enhance surgical outcomes, improve patient care, and optimize preoperative risk stratification. By integrating cutting-edge technologies, such as computer vision and machine learning, this research team aims to discover novel predictive models and decision-support systems that facilitate accurate staging and improve personalized therapeutic strategies for patients with hepatobiliary and pancreatic cancer.
Second field of interest is borderline and locally advanced pancreatic cancer with projects in liquid biopsies, radiomics and genetic profiling in relation to neo-adjuvant chemotherapy and the role of margin accentuation for optimal surgical outcomes using electrovaporation.
Professor Frederik Berrevoet obtained his medical degree at Ghent University after which he received his surgical training at the University Hospital in Ghent, University Hospital Saarland, Homburg, Germany and Albert Schweitzer Hospital in the Netherlands. He started as a fellow at the Department of General & HPB and Transplantation Surgery at the University Hospital Ghent in 2004 after which he became a consultant in this department in 2006. Since 2020 he is the Head of the Department for General and HPB Surgery and Liver Transplantation and Organ Procurement. He received the degree of doctor in Medical Science with his public defense of the thesis with the title ‘Progress in synthetic material in abdominal wall repair’ in September 2010 and he obtained the European Board of Surgery qualification in Hepato-biliary and pancreatic surgery in Zurich, Switzerland in December 2010 and became honorary Fellow of the European Board of Surgery for Abdominal wall Surgery in 2021.
Professor Berrevoet published more than 180 papers in his domain over the years, wrote several book chapters regarding pancreatic surgery and open abdomen mangement and has presented more than 500 times at national and international meetings. He is a current board member of the Scientific Advisory Committee of the European Hernia Society, past President of the Belgian Section of Abdominal Wall Surgery and former President of the Belgian Section for HPB surgery, as well as the current Vice-chair of the Educational Committee of the EAHPBA and a former member of the Scientific Committee of that Association and Treasurer and Belgian Representative for the European Union of Medical Specialists for HPB Surgery. He is the current General Secretary of the Royal Belgian Society of Surgery. He is reviewer for many scientific journals in his field and Associate (subject) editor for the Journals Hernia, Acta Chirurgica Belgica, Frontiers of Surgery for Visceral Surgery, Frontiers of Surgery Abdominal wall Surgery, Updates in Surgery and the International Journal of Abdominal Wall and Hernia Surgery.
- dr. Niki Rashidian (MD, PhD) - postdoctoral fellow
- Intraductal Papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study) on behalf of the Research and Scientific Committee of the e-AHPBA. International Journal of Surgery 2023 March 14. doi: 10.1097/JS90000000000000280
- Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study. Scientific Committee of the European-African Hepato-Pancreato-Biliary Association.Ann Surg Oncol. 2022 Dec 20. doi: 10.1245/s10434-022-12387-2. Online ahead of print.PMID: 36539580
- 90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial. Radiology. 2022 Jun;303(3):699-710. doi: 10.1148/radiol.211806. Epub 2022 Mar 8.PMID: 35258371 Clinical Trial.
- A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation. on behalf of the Scientific Research Committee of the European-African Hepato-Pancreato-Biliary Assocation (E-AHPBA). Langenbeck’s Archives of Surgery. https://doi.org/10.1007/s00423-022-02687-2
- Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activitation and biomarkers relevant for cholestatic liver disease. Genes & Diseases. doi:10.1016/j.gendis.2022.02.003.
- Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy. Langenbecks Arch Surg. 2021 Dec;406(8):2749-2757. doi: 10.1007/s00423-021-02219-4. Epub 2021 Jun 2. PMID: 34076718.